Variable | Visit | Group | n | CST I n (%) | CST III n (%) | CST IV n (%) | P valuea |
---|---|---|---|---|---|---|---|
Trial arm | ANC1 | Iron | 144 | 70 (48.6) | 39 (27.1) | 35 (24.3) | 0.518 |
Control | 136 | 61 (44.9) | 45 (33.1) | 30 (22.1) | |||
FINb | Iron | 349 | 121 (34.7) | 88 (25.2) | 140 (40.1) | 0.113 | |
Control | 341 | 140 (1.1) | 66 (19.4) | 135 (9.6) | |||
Iron deficiency, Adjusted ferritin | ANC1 | No | 249 | 118 (47.4) | 75 (30.1) | 56 (22.5) | 0.57 |
Yes | 27 | 10 (37.0) | 9 (33.3) | 8 (29.6) | |||
FINb | No | 620 | 237 (38.2) | 140 (22.6) | 243 (39.2) | 0.281 | |
Yes | 65 | 20 (30.8) | 13 (20.0) | 32 (49.2) | |||
Ratio sTfR/log ferritin | ANC1 | No | 247 | 120 (48.6) | 74 (30.0) | 53 (21.5) | 0.216 |
Yes | 32 | 11 (34.4) | 10 (31.2) | 11 (34.4) | |||
FINb | No | 544 | 205 (37.7) | 124 (22.8) | 215 (39.5) | 0.81 | |
Yes | 140 | 52 (37.1) | 29 (20.7) | 59 (42.1) | |||
Nugent scorec | ANC1 | 7-10 | 15 | 0 (0) | 1 (6.7) | 14 (93.3) | <0.001 |
4-6 | 31 | 7 (22.6) | 6 (19.4) | 18 (58.1) | <0.001 | ||
0-3 | 221 | 116 (52.5) | 74 (33.5) | 31 (14.0) | <0.001 | ||
FINb | 7-10 | 80 | 2 (2.5) | 6 (7.5) | 72 (90.0) | <0.001 | |
4-6 | 60 | 11 (18.3) | 6 (10.0) | 43 (71.7) | <0.001 | ||
0-3 | 501 | 232 (46.3) | 132 (26.3) | 137 (27.3) | <0.001 | ||
T. vaginalis | ANC1 | No | 243 | 121 (49.8) | 73 (30.0) | 49 (20.2) | 0.006 |
Yes | 37 | 10 (27.0) | 11 (29.7) | 16 (43.2) | |||
FINb | No | 655 | 260 (39.7) | 149 (22.7) | 246 (37.6) | <0.001 | |
Yes | 35 | 1 (2.9) | 5 (14.3) | 29 (82.9) | |||
High pH ≥ 4.5 | ANC1 | No | 123 | 73 (59.3) | 37 (30.1) | 13 (10.6) | <0.001 |
Yes | 153 | 58 (37.9) | 45 (29.4) | 50 (32.7) | |||
Vaginal discharge | ANC1 | No | 260 | 122 (46.9) | 80 (30.8) | 58 (22.3) | 0.268 |
Yes | 20 | 9 (4.5) | 4 (20.0) | 7 (35.0) | |||
FINb | No | 618 | 232 (37.5) | 144 (23.3) | 242 (39.2) | 0.205 | |
Yes | 69 | 28 (40.6) | 10 (14.5) | 31 (44.9) | |||
Antibiotics within previous three months | ANC1 | No | 252 | 118 (46.8) | 73 (29.0) | 61 (24.2) | NA |
Yes | 28 | 13 (46.4) | 11 (39.3) | 4 (14.3) | |||
FINb | No | 616 | 236 (38.3) | 136 (22.1) | 244 (39.6) | NA | |
Yes | 74 | 25 (33.8) | 18 (24.3) | 31 (41.9) |